SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+1.05%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$249M
AUM Growth
+$249M
(-25%)
Cap. Flow
-$78.1M
Cap. Flow
% of AUM
-31.36%
Top 10 Holdings %
Top 10 Hldgs %
61.55%
Holding
64
New
7
Increased
31
Reduced
6
Closed
11
Top Buys
| 1 |
Centene
CNC
|
$14.2M |
| 2 |
Disc Medicine
IRON
|
$11.2M |
| 3 |
Sanofi
SNY
|
$9.06M |
| 4 |
Edgewise Therapeutics
EWTX
|
$7.08M |
| 5 |
Maximus
MMS
|
$5.6M |
Top Sells
| 1 |
Icon
ICLR
|
$35.6M |
| 2 |
Zimmer Biomet
ZBH
|
$21.2M |
| 3 |
Labcorp
LH
|
$19.5M |
| 4 |
Teleflex
TFX
|
$14.9M |
| 5 |
Neurocrine Biosciences
NBIX
|
$10.9M |
Sector Composition
| 1 | Healthcare | 83.62% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Maximus
MMS
$4.95B
| $38.5M | 14.69% |
548,086
+79,734
| +17% | +$5.6M |
|
|
2
Disc Medicine
IRON
$2.07B
| $15.1M | 5.76% |
284,787
+211,276
| +287% | +$11.2M |
|
3
Globus Medical
GMED
$8.27B
| $14.5M | 5.54% |
245,570
+38,570
| +19% | +$2.28M |
|
|
4
Centene
CNC
$14.3B
| $14.2M | 5.44% |
+262,500
| New | +$14.2M |
|
5
Merck
MRK
$210B
| $13.8M | 5.26% |
173,951
-96,645
| -36% | -$7.65M |
|
|
DRUG
6
Bright Minds Biosciences
DRUG
$276M
| $13.4M | 5.11% |
512,338
+4,776
| +0.9% | +$125K |
|
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $12.7M | 4.84% |
100,725
-86,848
| -46% | -$10.9M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.4M | 4.73% |
225,114
+83,980
| +60% | +$4.62M |
|
9
Annexon
ANNX
$226M
| $9.83M | 3.75% |
4,095,764
+697,978
| +21% | +$1.68M |
|
|
10
Sanofi
SNY
$121B
| $9.06M | 3.46% |
+187,500
| New | +$9.06M |
|
11
Tyra Biosciences
TYRA
$675M
| $7.75M | 2.96% |
810,274
+393,657
| +94% | +$3.77M |
|
12
ANI Pharmaceuticals
ANIP
$2.03B
| $7.37M | 2.81% |
112,923
+25,625
| +29% | +$1.67M |
|
|
13
Edgewise Therapeutics
EWTX
$1.51B
| $7.08M | 2.7% |
+539,730
| New | +$7.08M |
|
|
AVR
14
Anteris Technologies Global Corp. Common Stock
AVR
$145M
| $6.97M | 2.66% |
1,839,022
-530,938
| -22% | -$2.01M |
|
|
SEPN
15
Septerna, Inc. Common Stock
SEPN
$539M
| $6.18M | 2.36% |
584,435
-204,235
| -26% | -$2.16M |
|
16
Artivion
AORT
$2.07B
| $4.94M | 1.89% |
158,736
+37,558
| +31% | +$1.17M |
|
17
Dianthus Therapeutics
DNTH
$759M
| $4.4M | 1.68% |
236,070
+119,073
| +102% | +$2.22M |
|
18
ProQR Therapeutics
PRQR
$237M
| $4.23M | 1.62% |
2,075,139
+20,546
| +1% | +$41.9K |
|
19
PMV Pharmaceuticals
PMVP
$74.2M
| $3.96M | 1.51% |
3,735,396
| – | – |
|
20
Avanos Medical
AVNS
$554M
| $3.54M | 1.35% |
288,849
+2,860
| +1% | +$35K |
|
21
Merus
MRUS
$4.98B
| $3.3M | 1.26% |
+62,719
| New | +$3.3M |
|
22
Aquestive Therapeutics
AQST
$456M
| $3.14M | 1.2% |
947,489
+555,860
| +142% | +$1.84M |
|
23
Ventyx Biosciences
VTYX
$171M
| $2.8M | 1.07% |
1,307,964
-1,274,691
| -49% | -$2.73M |
|
|
MBX
24
MBX Biosciences, Inc. Common Stock
MBX
$507M
| $2.75M | 1.05% |
+241,000
| New | +$2.75M |
|
25
IDEAYA Biosciences
IDYA
$2.15B
| $2.61M | 1% |
124,230
+1,230
| +1% | +$25.9K |
|